523 related articles for article (PubMed ID: 32859588)
1. Sex-dependent effect of
Gamache J; Yun Y; Chiba-Falek O
Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32859588
[TBL] [Abstract][Full Text] [Related]
2. APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review.
Forero DA; López-León S; González-Giraldo Y; Dries DR; Pereira-Morales AJ; Jiménez KM; Franco-Restrepo JE
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):126-142. PubMed ID: 27943569
[TBL] [Abstract][Full Text] [Related]
3. Role of apolipoprotein E polymorphism as a prognostic marker in traumatic brain injury and neurodegenerative disease: a critical review.
Maiti TK; Konar S; Bir S; Kalakoti P; Bollam P; Nanda A
Neurosurg Focus; 2015 Nov; 39(5):E3. PubMed ID: 26646927
[TBL] [Abstract][Full Text] [Related]
4. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Fernández-Calle R; Konings SC; Frontiñán-Rubio J; García-Revilla J; Camprubí-Ferrer L; Svensson M; Martinson I; Boza-Serrano A; Venero JL; Nielsen HM; Gouras GK; Deierborg T
Mol Neurodegener; 2022 Sep; 17(1):62. PubMed ID: 36153580
[TBL] [Abstract][Full Text] [Related]
5. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.
Krasemann S; Madore C; Cialic R; Baufeld C; Calcagno N; El Fatimy R; Beckers L; O'Loughlin E; Xu Y; Fanek Z; Greco DJ; Smith ST; Tweet G; Humulock Z; Zrzavy T; Conde-Sanroman P; Gacias M; Weng Z; Chen H; Tjon E; Mazaheri F; Hartmann K; Madi A; Ulrich JD; Glatzel M; Worthmann A; Heeren J; Budnik B; Lemere C; Ikezu T; Heppner FL; Litvak V; Holtzman DM; Lassmann H; Weiner HL; Ochando J; Haass C; Butovsky O
Immunity; 2017 Sep; 47(3):566-581.e9. PubMed ID: 28930663
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E in lipid metabolism and neurodegenerative disease.
Yang LG; March ZM; Stephenson RA; Narayan PS
Trends Endocrinol Metab; 2023 Aug; 34(8):430-445. PubMed ID: 37357100
[TBL] [Abstract][Full Text] [Related]
7. Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
Shang Y; Mishra A; Wang T; Wang Y; Desai M; Chen S; Mao Z; Do L; Bernstein AS; Trouard TP; Brinton RD
PLoS One; 2020; 15(1):e0225392. PubMed ID: 31917799
[TBL] [Abstract][Full Text] [Related]
8. Factors Influencing Alzheimer's Disease Risk: Whether and How They are Related to the APOE Genotype.
Zhang R; Xu X; Yu H; Xu X; Wang M; Le W
Neurosci Bull; 2022 Jul; 38(7):809-819. PubMed ID: 35149974
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.
Dilliott AA; Evans EC; Farhan SMK; Ghani M; Sato C; Zhang M; McIntyre AD; Cao H; Racacho L; Robinson JF; Strong MJ; Masellis M; Bulman DE; Rogaeva E; Black SE; Finger E; Frank A; Freedman M; Hassan A; Lang A; Shoesmith CL; Swartz RH; Tang-Wai D; Tartaglia MC; Turnbull J; Zinman L; ; Hegele RA
Can J Neurol Sci; 2019 Sep; 46(5):491-498. PubMed ID: 31217043
[TBL] [Abstract][Full Text] [Related]
10. Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
Rezazadeh M; Khorrami A; Yeghaneh T; Talebi M; Kiani SJ; Heshmati Y; Gharesouran J
Neuromolecular Med; 2016 Mar; 18(1):37-49. PubMed ID: 26553058
[TBL] [Abstract][Full Text] [Related]
11. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
[TBL] [Abstract][Full Text] [Related]
12. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
13. APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention.
Zhou X; Fu AK; Ip NY
Curr Opin Neurobiol; 2021 Aug; 69():58-67. PubMed ID: 33647674
[TBL] [Abstract][Full Text] [Related]
14. ApoE and Neurodegenerative Diseases in Aging.
Yin Y; Wang Z
Adv Exp Med Biol; 2018; 1086():77-92. PubMed ID: 30232753
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
Marshe VS; Gorbovskaya I; Kanji S; Kish M; Müller DJ
J Neural Transm (Vienna); 2019 Jan; 126(1):65-85. PubMed ID: 30382407
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice.
Maldonado Weng J; Parikh I; Naqib A; York J; Green SJ; Estus S; LaDu MJ
Mol Neurodegener; 2019 Dec; 14(1):47. PubMed ID: 31861986
[TBL] [Abstract][Full Text] [Related]
17. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration.
Obulesu M; Somashekhar R; Venu R
Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304
[TBL] [Abstract][Full Text] [Related]
18. The role of APOE in transgenic mouse models of AD.
Balu D; Karstens AJ; Loukenas E; Maldonado Weng J; York JM; Valencia-Olvera AC; LaDu MJ
Neurosci Lett; 2019 Aug; 707():134285. PubMed ID: 31150730
[TBL] [Abstract][Full Text] [Related]
19. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
20. Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
Qiu C; Kivipelto M; Agüero-Torres H; Winblad B; Fratiglioni L
J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):828-33. PubMed ID: 15145993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
